TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance.

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

Medtronic recently delivered strong quarterly results thanks to a fast-growing franchise. This tailwind, along with others, could help maintain the stock's momentum into 2026. Plus, there are also ...

Issuing a largely positive outlook on the MedTech sector for 2026, Citi on Thursday upgraded Penumbra (PEN) and Bausch + Lomb ...

DexCom recently announced the upcoming U.S. launch of its G7 15 Day Continuous Glucose Monitoring system and received FDA clearance for its Smart Basal insulin dosing optimizer, both targeting ...

Tandem (TNDM) stock was upgraded, and Zimmer (ZBH) stock and ResMed (RMD) stock were downgraded as part of Baird's 2026 ...

Discover why DexCom (DXCM) could rebound in 2025. Explore buyback plans, growth potential, and investment insights in the ...

An Oxford researcher has found that transparent conducting electrodes can reduce perovskite–silicon tandem solar cell ...

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) announces that, on November 25, 2025, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client Boston ...

Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...